Evidence map›Paper›PMID 36121894›Full record

ArticlePLoS pathogens2022

Characterization of dengue virus 3'UTR RNA binding proteins in mosquitoes reveals that AeStaufen reduces subgenomic flaviviral RNA in saliva.

Shih-Chia Yeh, Mayra Diosa-Toro, Wei-Lian Tan, Florian Rachenne, Arthur Hain, Celestia Pei Xuan Yeo, Inès Bribes, Benjamin Wong Wei Xiang, Gayathiri Sathiamoorthy Kannan, Menchie Casayuran Manuel and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Shih-Chia YehProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Republic of Singapore.
Mayra Diosa-ToroProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Republic of Singapore.
Wei-Lian TanProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Republic of Singapore.
Florian RachenneMIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
Arthur HainProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Republic of Singapore.
Celestia Pei Xuan YeoProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Republic of Singapore.
Inès BribesMIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
Benjamin Wong Wei XiangProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Republic of Singapore.
Gayathiri Sathiamoorthy KannanDepartment of Biological Sciences, National University of Singapore, Singapore, Republic of Singapore.
Menchie Casayuran ManuelProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Republic of Singapore.
Dorothée MisséMIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
Yu Keung MokDepartment of Biological Sciences, National University of Singapore, Singapore, Republic of Singapore.
Julien PomponProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Republic of Singapore.ORCID 0000-0003-1110-9039
Duke-NUS Medical School · SGCentre National de la Recherche Scientifique · FRNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue viruses (DENV) are expanding global pathogens that are transmitted through the bite of mosquitoes, mostly Aedes aegypti. As RNA viruses, DENV rely on RNA-binding proteins (RBPs) to complete their life cycle. Alternatively, RBPs can act as restriction factors that prevent DENV multiplication. While the importance of RBPs is well-supported in humans, there is a dearth of information about their influence on DENV transmission by mosquitoes. Such knowledge could be harnessed to design novel, effective interventions against DENV. Here, we successfully adapted RNA-affinity chromatography coupled with mass spectrometry-a technique initially developed in mammalian cells-to identify RBPs in Ae. aegypti cells. We identified fourteen RBPs interacting with DENV serotype 2 3'UTR, which is involved in the viral multiplication and produces subgenomic flaviviral RNA (sfRNA). We validated the RNA affinity results for two RBPs by confirming that AePur binds the 3'UTR, whereas AeStaufen interacts with both 3'UTR and sfRNA. Using in vivo functional evaluation, we determined that RBPs like AeRan, AeExoRNase, and AeRNase have pro-viral functions, whereas AeGTPase, AeAtu, and AePur have anti-viral functions in mosquitoes. Furthermore, we showed that human and mosquito Pur homologs have a shared affinity to DENV2 RNA, although the anti-viral effect is specific to the mosquito protein. Importantly, we revealed that AeStaufen mediates a reduction of gRNA and sfRNA copies in several mosquito tissues, including the salivary glands and that AeStaufen-mediated sfRNA reduction diminishes the concentration of transmission-enhancing sfRNA in saliva, thereby revealing AeStaufen's role in DENV transmission. By characterizing the first RBPs that associate with DENV2 3'UTR in mosquitoes, our study unravels new pro- and anti-viral targets for the design of novel therapeutic interventions as well as provides foundation for studying the role of RBPs in virus-vector interactions.

Indexed as

AedesDengueDengue Virus3' Untranslated RegionsAnimalsCarrier ProteinsHumansMammalsMosquito VectorsRNA-Binding ProteinsSaliva3' Untranslated RegionsCarrier ProteinsRNA-Binding Proteins

Identifiers

PMID36121894
PMCPMC9531803
OpenAlexW4296329189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.